Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30013779
Basic Information
VIS ID
TVIS30013779
Fusion event
HIV-PRRC2B integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr9
Cytoband
q34.13
Reference genome
GRCh37/hg19
Start
134323249/131447862 (Hg38)
End
134323249/131447862 (Hg38)
Orient
-
Location type
Intronic
Target gene
PRRC2B
miRNAs that regulate target gene
hsa-mir-1910-5p
;
hsa-mir-1284
;
hsa-mir-877-3p
;
hsa-mir-296-3p
;
hsa-mir-615-3p
;
hsa-mir-92b-3p
;
hsa-mir-505-3p
;
hsa-mir-193b-3p
;
hsa-mir-484
;
hsa-mir-324-3p
;
hsa-mir-331-3p
;
hsa-mir-181a-5p
;
hsa-mir-34a-5p
;
hsa-mir-92a-3p
;
hsa-let-7b-5p
;
hsa-mir-25-3p
;
hsa-mir-32-5p
;
hsa-mir-363-3p
;
hsa-mir-367-3p
;
hsa-mir-497-3p
;
hsa-mir-500a-3p
;
hsa-mir-3153
;
hsa-mir-4681
;
hsa-mir-6077
;
hsa-mir-6733-5p
;
hsa-mir-6739-5p
;
hsa-mir-6804-3p
;
hsa-mir-143-3p
;
hsa-mir-4251
;
hsa-mir-4770
;
hsa-mir-6088
;
hsa-mir-762
;
hsa-mir-5001-5p
;
hsa-mir-4498
;
hsa-mir-4492
;
hsa-mir-3135b
;
hsa-mir-4446-3p
;
hsa-mir-6753-5p
;
hsa-mir-1911-3p
;
hsa-mir-147a
;
hsa-mir-4474-3p
;
hsa-mir-620
;
hsa-mir-1270
;
hsa-mir-644a
;
hsa-mir-198
;
hsa-mir-6880-5p
;
hsa-mir-4683
;
hsa-mir-7109-5p
;
hsa-mir-5572
;
hsa-mir-4260
;
hsa-mir-450a-2-3p
;
hsa-mir-6855-5p
;
hsa-mir-3170
;
hsa-mir-6819-5p
;
hsa-mir-6812-5p
;
hsa-mir-6737-5p
;
hsa-mir-4665-5p
;
hsa-mir-1275
;
hsa-mir-4472
;
hsa-mir-4447
;
hsa-mir-92a-2-5p
;
hsa-mir-6766-5p
;
hsa-mir-6747-5p
;
hsa-mir-6756-5p
;
hsa-mir-4651
;
hsa-mir-608
;
hsa-mir-4664-5p
;
hsa-mir-342-5p
;
hsa-mir-5010-5p
;
hsa-mir-4525
;
hsa-mir-7111-5p
;
hsa-mir-6870-5p
;
hsa-mir-5698
;
hsa-mir-4723-5p
;
hsa-mir-625-5p
;
hsa-mir-6825-5p
;
hsa-mir-765
;
hsa-mir-4784
;
hsa-mir-4533
;
hsa-mir-3150b-3p
;
hsa-mir-5002-5p
;
hsa-mir-6876-5p
;
hsa-mir-4476
;
hsa-mir-651-3p
;
hsa-mir-7106-5p
;
hsa-mir-1252-5p
;
hsa-mir-2681-5p
;
hsa-mir-501-5p
;
hsa-mir-500a-5p
;
hsa-mir-6771-3p
;
hsa-mir-548as-3p
;
hsa-mir-335-3p
;
hsa-mir-5096
;
hsa-mir-3684
;
hsa-mir-3682-5p
;
hsa-mir-4699-3p
;
hsa-mir-494-3p
;
hsa-mir-129-5p
;
hsa-mir-3680-3p
;
hsa-mir-557
;
hsa-mir-507
;
hsa-mir-450b-5p
;
hsa-mir-527
;
hsa-mir-518a-5p
;
hsa-mir-548aw
;
hsa-mir-4290
;
hsa-mir-627-3p
;
hsa-mir-548b-3p
;
hsa-mir-1273f
;
hsa-mir-185-3p
;
hsa-mir-28-5p
;
hsa-mir-3128
;
hsa-mir-3139
;
hsa-mir-3140-3p
;
hsa-mir-31-5p
;
hsa-mir-3163
;
hsa-mir-3184-5p
;
hsa-mir-3202
;
hsa-mir-3975
;
hsa-mir-423-5p
;
hsa-mir-4468
;
hsa-mir-4775
;
hsa-mir-5000-5p
;
hsa-mir-5187-5p
;
hsa-mir-548az-5p
;
hsa-mir-548n
;
hsa-mir-548t-5p
;
hsa-mir-5690
;
hsa-mir-5705
;
hsa-mir-6081
;
hsa-mir-6085
;
hsa-mir-6090
;
hsa-mir-6506-3p
;
hsa-mir-658
;
hsa-mir-6728-5p
;
hsa-mir-6779-5p
;
hsa-mir-6809-5p
;
hsa-mir-6813-5p
;
hsa-mir-6858-5p
;
hsa-mir-708-5p
;
hsa-mir-7515
;
hsa-mir-7846-3p
Nearest miRNA
hsa-let-7a-1/Upstream/821499; hsa-mir-126/Downstream/1497845;
Nearest TSS
ENST00000422679/Upstream/1357;
ENST00000422467/Downstream/7281;
Nearest CpG islands
None/Target,
chr9-CpG: 64/Upstream/52997
,
chr9-CpG: 63/Downstream/27495
Upstream sequence
GCCTTGACGATCTGGACGCCGATGCCGATGATGGCTGGGCAGGTGGGCAGAGAAGCACGGGTGGTTTAGACGGGCAGGACCAAAGTCCATATGTACTTAC
Downstream sequence
CAGGGATGGAAACCCCCTGGCACCACCGTGTGTTTTCCCTTGGCAAGATAGGGATGAAGAGCCGGACAGGGAAGCAGACCTGATGCCCTCCTTCCTCATT
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Resting CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate